These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21520178)

  • 1. Transforming growth factor-β adaptor, β2-spectrin, modulates cyclin dependent kinase 4 to reduce development of hepatocellular cancer.
    Baek HJ; Pishvaian MJ; Tang Y; Kim TH; Yang S; Zouhairi ME; Mendelson J; Shetty K; Kallakury B; Berry DL; Shin KH; Mishra B; Reddy EP; Kim SS; Mishra L
    Hepatology; 2011 May; 53(5):1676-84. PubMed ID: 21520178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β2 spectrin-mediated differentiation repressed the properties of liver cancer stem cells through β-catenin.
    Chen Y; Meng L; Shang H; Dou Q; Lu Z; Liu L; Wang Z; He X; Song Y
    Cell Death Dis; 2018 Apr; 9(4):424. PubMed ID: 29555987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CEACAM1 long cytoplasmic domain isoform is associated with invasion and recurrence of hepatocellular carcinoma.
    Kiriyama S; Yokoyama S; Ueno M; Hayami S; Ieda J; Yamamoto N; Yamaguchi S; Mitani Y; Nakamura Y; Tani M; Mishra L; Shively JE; Yamaue H
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4(0 4):S505-14. PubMed ID: 24390710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of transforming growth factor-beta signaling through beta-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation.
    Kitisin K; Ganesan N; Tang Y; Jogunoori W; Volpe EA; Kim SS; Katuri V; Kallakury B; Pishvaian M; Albanese C; Mendelson J; Zasloff M; Rashid A; Fishbein T; Evans SR; Sidawy A; Reddy EP; Mishra B; Johnson LB; Shetty K; Mishra L
    Oncogene; 2007 Nov; 26(50):7103-10. PubMed ID: 17546056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of transforming growth factor β adaptor protein β-2 spectrin leads to delayed liver regeneration in mice.
    Thenappan A; Shukla V; Abdul Khalek FJ; Li Y; Shetty K; Liu P; Li L; Johnson RL; Johnson L; Mishra L
    Hepatology; 2011 May; 53(5):1641-50. PubMed ID: 21520177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL6-mediated inflammatory loop reprograms normal to epithelial-mesenchymal transition
    Mitra A; Yan J; Xia X; Zhou S; Chen J; Mishra L; Li S
    Hepatology; 2017 Apr; 65(4):1222-1236. PubMed ID: 27863449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of transforming growth factor beta signaling and expansion of progenitor cells in regenerating liver.
    Thenappan A; Li Y; Kitisin K; Rashid A; Shetty K; Johnson L; Mishra L
    Hepatology; 2010 Apr; 51(4):1373-82. PubMed ID: 20131405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling.
    Lin L; Amin R; Gallicano GI; Glasgow E; Jogunoori W; Jessup JM; Zasloff M; Marshall JL; Shetty K; Johnson L; Mishra L; He AR
    Oncogene; 2009 Feb; 28(7):961-72. PubMed ID: 19137011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFβ Signaling.
    Chen J; Mitra A; Li S; Song S; Nguyen BN; Chen JS; Shin JH; Gough NR; Lin P; Obias V; He AR; Yao Z; Malta TM; Noushmehr H; Latham PS; Su X; Rashid A; Mishra B; Wu RC; Mishra L
    Cancer Res; 2020 May; 80(9):1819-1832. PubMed ID: 32127355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of TGF-β adaptor β2SP activates notch signaling and SOX9 expression in esophageal adenocarcinoma.
    Song S; Maru DM; Ajani JA; Chan CH; Honjo S; Lin HK; Correa A; Hofstetter WL; Davila M; Stroehlein J; Mishra L
    Cancer Res; 2013 Apr; 73(7):2159-69. PubMed ID: 23536563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular cancer arises from loss of transforming growth factor beta signaling adaptor protein embryonic liver fodrin through abnormal angiogenesis.
    Baek HJ; Lim SC; Kitisin K; Jogunoori W; Tang Y; Marshall MB; Mishra B; Kim TH; Cho KH; Kim SS; Mishra L
    Hepatology; 2008 Oct; 48(4):1128-37. PubMed ID: 18704924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heme oxygenase-1/carbon monoxide axis suppresses transforming growth factor-β1-induced growth inhibition by increasing ERK1/2-mediated phosphorylation of Smad3 at Thr-179 in human hepatocellular carcinoma cell lines.
    Park SJ; Lee SK; Lim CR; Park HW; Liu F; Kim SJ; Kim BC
    Biochem Biophys Res Commun; 2018 Apr; 498(3):609-615. PubMed ID: 29524413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferative suppression by CDK4/6 inhibition: complex function of the retinoblastoma pathway in liver tissue and hepatoma cells.
    Rivadeneira DB; Mayhew CN; Thangavel C; Sotillo E; Reed CA; Graña X; Knudsen ES
    Gastroenterology; 2010 May; 138(5):1920-30. PubMed ID: 20100483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The upregulation of stromal antigen 3 expression suppresses the phenotypic hallmarks of hepatocellular carcinoma through the Smad3-CDK4/CDK6-cyclin D1 and CXCR4/RhoA pathways.
    Zhao M; Wang Y; Zhang Y; Li X; Mi J; Wang Q; Geng Z; Zuo L; Song X; Ge S; Zhang Z; Tang M; Li H; Wang Z; Jiang C; Su F
    BMC Gastroenterol; 2022 Aug; 22(1):378. PubMed ID: 35941537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRMT5 competitively binds to CDK4 to promote G1-S transition upon glucose induction in hepatocellular carcinoma.
    Yang H; Zhao X; Zhao L; Liu L; Li J; Jia W; Liu J; Huang G
    Oncotarget; 2016 Nov; 7(44):72131-72147. PubMed ID: 27708221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β/β2-spectrin/CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndrome.
    Chen J; Yao ZX; Chen JS; Gi YJ; Muñoz NM; Kundra S; Herlong HF; Jeong YS; Goltsov A; Ohshiro K; Mistry NA; Zhang J; Su X; Choufani S; Mitra A; Li S; Mishra B; White J; Rashid A; Wang AY; Javle M; Davila M; Michaely P; Weksberg R; Hofstetter WL; Finegold MJ; Shay JW; Machida K; Tsukamoto H; Mishra L
    J Clin Invest; 2016 Feb; 126(2):527-42. PubMed ID: 26784546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
    Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
    Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin-dependent kinase 4-mediated phosphorylation inhibits Smad3 activity in cyclin D-overexpressing breast cancer cells.
    Zelivianski S; Cooley A; Kall R; Jeruss JS
    Mol Cancer Res; 2010 Oct; 8(10):1375-87. PubMed ID: 20736297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of cooperative function of transforming growth factor-beta signaling proteins, smad3 with embryonic liver fodrin, a beta-spectrin, in primary biliary cirrhosis.
    Mishra B; Tang Y; Katuri V; Fleury T; Said AH; Rashid A; Jogunoori W; Mishra L
    Liver Int; 2004 Dec; 24(6):637-45. PubMed ID: 15566516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucin1 mediates autocrine transforming growth factor beta signaling through activating the c-Jun N-terminal kinase/activator protein 1 pathway in human hepatocellular carcinoma cells.
    Li Q; Liu G; Shao D; Wang J; Yuan H; Chen T; Zhai R; Ni W; Tai G
    Int J Biochem Cell Biol; 2015 Feb; 59():116-25. PubMed ID: 25526895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.